Contents -- Contributors -- Preface -- SECTION I: DISORDERS DUE TO PRIMARY HIV-1 PATHOGENESIS AND THEIR TREATMENT -- 1. HIV-1-Associated Neurocognitive Disorders in the HAART Era -- 2. Evolution of Neuropsychological Issues in HIV-1 Infection during the HAART Era -- 3. HIV Infection and Stroke: the Changing Face of a Rising Problem -- 4. HIV-Associated Myelopathy, Myopathy, and Meningitis -- 5. Investigation and Presentation of Autonomic Neuropathies in HIV Infection -- 6. Distal Sensory Polyneuropathy and Other Selected Neuropathies in HIV Infection -- 7. Mitochondrial Dysfunction and Lactic Acidosis in HIV Disease -- 8. Neurologic Outcomes in HIV Infection: Clinical Events and Surrogate Markers -- 9. Designing HIV gp120 Peptide Vaccines: Rhetoric or Reality for Neuro-AIDS -- SECTION II: PATHOPHYSIOLOGICAL ISSUES -- 10. Neurovirological Aspects of HIV Infection in the HAART Era -- 11. Neuroimmunology and the Pathogenesis of HIV-1 Encephalitis in the HAART Era: Implications for Neuroprotective Treatment -- 12. Chemokines and the Neuropathogenesis of HIV-1 Infection -- 13. Cerebrospinal Fluid Markers in the Management of Central Nervous System HIV Infection and the AIDS Dementia Complex -- 14. The Neuropathology of HIV Pre- and Post-HAART -- 15. The Role of Viral Genetic Variability in HIV-Associated Neurocognitive Disorder -- 16. Antioxidants and Brain Function in HIV/AIDS -- 17. Cell Cycle Proteins and the Pathogenesis of HIV-1 Encephalitis in the HAART Era -- SECTION III: NEUROIMAGING IN HIV INFECTION -- 18. The Uses of Structural Neuroimaging in the Brain in HIV-1-Infected Patients -- 19. Functional Magnetic Resonance Imaging in HIV-Associated Dementia -- 20. Magnetic Resonance Spectroscopy in HIV-Associated Brain Injury -- SECTION IV: HIV COMORBIDITIES -- 21. Hepatitis C Virus: Variability, Extrahepatic Replication, and Neuroinvasion.

22. Toxoplasmosis of the Central Nervous System -- 23. Basic and Clinical Aspects of Human Cytomegalovirus Infection -- 24. Cryptococcosis and Other Fungal Infections of the Central Nervous System -- 25. Neurosyphilis in AIDS -- 26. Progressive Multifocal Leukoencephalopathy in the Era of HAART -- 27. Epstein-Barr Virus Infection and Primary Central Nervous System Lymphoma -- 28. Mood Disorders, Delirium, and Other Neurobehavioral Symptoms and Disorders in the HAART Era -- 29. Substance Use Disorders and Neuro-AIDS in the HAART Era -- SECTION V: SPECIAL POPULATIONS AND NEURO-AIDS -- 30. Ethnicity and Neuro-AIDS Conditions in the HAART Era -- 31. Women and Neuro-AIDS Conditions in the Era of HAART -- 32. Pediatric Neuro-AIDS -- 33. Interaction of the Aging Process with Neurobehavioral and Neuro-AIDS Conditions in the HAART Era -- SECTION VI: SPECIAL HEALTH CARE ISSUES AND NEURO-AIDS -- 34. Neurologic Aspects of Palliative Care for HIV/AIDS -- 35. Medico-Legal Issues in HIV/AIDS in the 21st Century -- 36. Global Issues in Neuro-AIDS and Their Evolution over the Future of the HAART Era -- Index -- A -- B -- C -- D -- E -- F -- G -- H -- I -- J -- K -- L -- M -- N -- O -- P -- Q -- R -- S -- T -- U -- V -- W -- Z.